Analyst Insights and Signify Premium Insights

Cranfield, UK, 25th April 2024 - Over $5.3 billion has been raised by medical...

23 April 2024, Investment into AI-based software across medical diagnostics and clinical care has been notably boom-or-bust in the last decade. Radiology has long been the “poster child” for funding and penetration of healthcare markets, with over $5.6B raised to date resulting in well-known successes such as Heartflow, viz.ai, annalise.ai and Ultromics.

22nd April 2024, USCAP’s annual meeting is one of the largest annual gatherings of pathologists globally, so when landing in Baltimore this year for the 113th event, we were eager to connect with industry leaders old and new to discuss their take on the ‘pulse’ of the conference and what it meant for the future of clinical pathology.

In recent months, the US Department of Health and Human Services (HHS) made several announcements promoting the development of health information exchanges (HIE). 

Insight into both the current and future of the outpatient market and what Imaging IT vendors will need to consider when operating in or looking to enter the market. Also some insight into the role and influence of private equity in the outpatient market.

Over the last 12 months, Signify Research has tracked generative AI (gen AI) product announcements in healthcare to understand the most prevalent use cases and those lacking traction.

The Remote Patient Monitoring (RPM) market, though still facing a number of teething issues, has potential for significant levels of growth over the coming years. Since Signify Research’s 2022 iteration of its Remote Patient Monitoring – World report, the market has evolved, but still faces several of the same challenges as it did two years ago. The push both during and post-Covid towards more decentralized and virtual models of care delivery continue to steer the market towards further RPM adoption, the pressures regarding a challenging economic climate remain, along with providers burdened with tight operating margins and the ever-present issue of staffing shortages.

This insight provides an overview of the key developments witnessed at HIMSS from our teams that were in attendance in Orlando earlier this month. The insight is broken down into four areas of the healthcare technology industry:

The Signify Research team had the pleasure of attending HIMSS 2024 in Orlando. Conversations in imaging informatics varied, from renewed interest in VNAs and the potential of enterprise imaging, to evaluating how reporting will evolve short and mid-term, and most evidently – cloud adoption.

Explore how the progress in transabdominal fetal monitoring is addressing challenges in fetal monitoring. While recent advancements are overcoming obstacles, there are still limitations that must be addressed in future developments to enhance widespread adoption.

Medical imaging AI is increasingly included within radiology IT tenders, with imaging IT vendors needing to address how the integration of AI image analysis tools into the workflow will be achieved.

ECR 2024 illuminated the horizon of medical imaging, unveiling a seamless fusion of product breakthroughs and refined techniques that herald a new era in radiology. The overarching theme of this year's European Congress of Radiology encapsulated the dynamic evolution of the medical imaging landscape to capture the latest pioneering advancements.